HMP Global July 22, 2024
Malinka Walaliyadde, CEO, Co-Founder, AKASA

Can you share a brief overview of your professional history?

My name is Malinka Walaliyadde, and I am the CEO and a co-founder of AKASA, the preeminent provider of generative AI solutions for the health care revenue cycle. Before AKASA, I was a partner at Andreessen Horowitz (a16z), a Silicon Valley venture capital firm with $42B in assets under management. I helped start their health care investment team and worked on almost $250M of investments across 20 health care companies, including providers, payers, biotech, and health technology.

My co-founders and I started AKASA because we all noticed a common trend: no one was solving the pervasive issues in the back end of health care with modern approaches. There was...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Provider, RCM (Revenue Cycle Mgmt), Technology, Trends
Related Articles:
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article